Literature DB >> 15001840

Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates.

E P Smorodin1, O A Kurtenkov, B L Sergeyev, G V Pazynina, N V Bovin.   

Abstract

The TF, Tn, and SiaTn glycotopes are frequently expressed in cancer-associated mucins. Antibodies to these glycotopes were found in human serum. A set of polyacrylamide (PAA)--based glycoconjugates was applied to the direct and competitive enzyme-linked immunosorbent assays (ELISA) to characterize the specificity of serum IgG antibodies. The anti-TF, -Tn and -SiaTn IgG were affinity purified from serum of cancer patients and characterized using PAA-conjugates and free saccharides. The anti-TF and -Tn antibodies were shown to be specific. The anti-TF IgG bound both Galbeta1-3GalNAcalpha- and Galbeta1-3GalNAcbeta-PAA, the latter was three-four times more effective inhibitor of antibody binding. The anti-Tn IgG reacted only with GalNAcalpha-PAA. The anti-SiaTn IgG cross-reacted with Tn-PAA but SiaTn-PAA was five-six times more effective inhibitor in a competitive assay. The IC50 values for PAA-conjugates with the corresponding antibodies typically ranged from 2 to 5 x 10(-8) M. The antibodies display a low specificity to mucin-type glycoconjugates in comparison with PAA-conjugates as was shown for mucins isolated from human malignant tumor tissues, ovine submaxillary mucin (OSM) and asialo-OSM. The unusual IgG-antibody specificity to GalNAcbeta and GalNAcbeta1-3GalNAcbeta ligands was found in human serum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001840     DOI: 10.1023/B:GLYC.0000018582.83813.04

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  16 in total

1.  Colorimetric determination of N-acetylhexosamine-terminating O-glycosidically linked saccharides in mucins and glycoproteins.

Authors:  V P Bhavanandan; M Sheykhnazari; H Devaraj
Journal:  Anal Biochem       Date:  1990-07       Impact factor: 3.365

2.  Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft model.

Authors:  D Avichezer; G F Springer; B Schechter; R Arnon
Journal:  Int J Cancer       Date:  1997-07-03       Impact factor: 7.396

3.  Elucidation of an essential structure recognized by an anti-GalNAc alpha-Ser(Thr) monoclonal antibody (MLS 128).

Authors:  H Nakada; Y Numata; M Inoue; N Tanaka; H Kitagawa; I Funakoshi; S Fukui; I Yamashina
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

4.  [ELISA of IgM antibodies to Thomsen-Friedenreich (TF) hapten in cancer diagnostics: comparison of data obtained with four TF-glycoconjugates].

Authors:  E P Smorodin; B Jansson; L Miliukhina; G Paaski; N V Bovin; T V Ovchinnikova; O Kurtenkov
Journal:  Bioorg Khim       Date:  1997-10

5.  Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.

Authors:  S Adluri; F Helling; S Ogata; S Zhang; S H Itzkowitz; K O Lloyd; P O Livingston
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

6.  The sensitivity and specificity of anti-GM1 antibody testing.

Authors:  B V Taylor; L Gross; A J Windebank
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

Review 7.  Polyacrylamide-based glycoconjugates as tools in glycobiology.

Authors:  N V Bovin
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

8.  Origin of anti-Thomsen-Friedenreich (T) and Tn agglutinins in man and in White Leghorn chicks.

Authors:  G F Springer; H Tegtmeyer
Journal:  Br J Haematol       Date:  1981-03       Impact factor: 6.998

9.  Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection.

Authors:  P R Desai; L H Ujjainwala; S C Carlstedt; G F Springer
Journal:  J Immunol Methods       Date:  1995-12-27       Impact factor: 2.303

10.  A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAc alpha(2----6)GalNAc, in mucin-type glycoproteins.

Authors:  A Kurosaka; H Kitagawa; S Fukui; Y Numata; H Nakada; I Funakoshi; T Kawasaki; T Ogawa; H Iijima; I Yamashina
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

View more
  5 in total

1.  Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.

Authors:  Eugeniy-P Smorodin; Oleg-A Kurtenkov; Boris-L Sergeyev; Kristel-E Kodar; Valentin-I Chuzmarov; Vladimir-P Afanasyev
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

2.  Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.

Authors:  Tatiana Pochechueva; Francis Jacob; Andre Fedier; Viola Heinzelmann-Schwarz
Journal:  Metabolites       Date:  2012-11-14

3.  The relation of the level of serum anti-TF, -Tn and -alpha-Gal IgG to survival in gastrointestinal cancer patients.

Authors:  Eugeniy Smorodin; Boris Sergeyev; Kersti Klaamas; Valentin Chuzmarov; Oleg Kurtenkov
Journal:  Int J Med Sci       Date:  2013-09-23       Impact factor: 3.738

Review 4.  Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer.

Authors:  Eugeniy P Smorodin
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 5.  Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential.

Authors:  Oleg Kurtenkov
Journal:  Biomed Res Int       Date:  2020-03-23       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.